Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder
about
Neuroanatomic and cognitive abnormalities in attention-deficit/hyperactivity disorder in the era of 'high definition' neuroimagingResponse inhibition and interference control in obsessive-compulsive spectrum disordersChanges in behavior as side effects in methylphenidate treatment: review of the literatureGenetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.Real-time fMRI neurofeedback in adolescents with attention deficit hyperactivity disorder.ADHD, Multimodal Treatment, and Longitudinal Outcome: Evidence, Paradox, and ChallengeAttention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Dopaminergic system dysfunction in recreational dexamphetamine usersGuanfacine Extended Release: A New Pharmacological Treatment Option in Europe.The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal taskImpact of ADHD and cannabis use on executive functioning in young adults.Network Structure among Brain Systems in Adult ADHD is Uniquely Modified by Stimulant Administration.Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder.Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment.ADHD diagnosis may influence the association between polymorphisms in nicotinic acetylcholine receptor genes and tobacco smoking.Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.The Effects of Stimulant Medication and Training on Sports Competence Among Children With ADHD.The effects of individual upper alpha neurofeedback in ADHD: an open-label pilot study.Differential long-term medication impact on executive function and delay aversion in ADHD.Attention Functioning Among Adolescents With Multiple Learning, Attentional, Behavioral, and Emotional Difficulties.High IQ May "Mask" the Diagnosis of ADHD by Compensating for Deficits in Executive Functions in Treatment-Naïve Adults With ADHD.A neurocomputational account of reward and novelty processing and effects of psychostimulants in attention deficit hyperactivity disorder.Stimulant Withdrawal in a Child with Autism Spectrum Disorder and ADHD - A Case Report.Silencing of Syntaxin 1A in the Dopaminergic Neurons Decreases the Activity of the Dopamine Transporter and Prevents Amphetamine-Induced Behaviors in C. elegans.
P2860
Q26859175-1764AD73-D000-4715-ACEE-0A062C14C463Q26863507-5B731C5D-A0DC-4848-8EB0-B353B9E36E38Q28078623-95166C5E-4B79-41AD-B428-54DC4758BC20Q28652508-228248E4-1AEF-4B47-8A99-BB7C724209C3Q30572214-D767C86A-DA17-4EA2-B7BE-78408BED47CFQ33697918-AD9B7E8C-BB88-4549-9F5F-AD18070E7602Q34456523-0D392B06-8DE7-4275-B582-054BCB5A6D47Q34461113-8250E647-F3A6-41D7-9345-93527BB3B712Q35200020-C6BD30A0-068C-4416-A384-C1CEB670F5A6Q36446854-8BA0DC0A-6DFD-470D-968B-F08C8EA28C3CQ36816544-563644AC-9FD5-49E7-A05D-C4946F22CFE7Q37286873-E66B0692-6599-4680-8D55-DBF8698A1350Q38406698-2F57A4E6-F090-48AD-B38D-FE90534D9B75Q38891978-91E575B6-06E1-472A-BF98-C880C736A743Q39735203-BD53AFE7-6B88-46AE-9201-9291634850B8Q46093396-5EC4B517-4A75-43A6-9120-1FDEA138ABF7Q47338555-7A343311-7258-4CEA-95FA-EEBD52358322Q47823342-CE341C3F-C684-4779-A163-654263812510Q48557960-CEC5CC42-80F6-4CF5-9506-ABF5DE9889A7Q49821724-2F0D3F35-83FB-44D7-8E90-F633DBED2286Q50590964-4997A225-FA9E-4FCC-9598-B13D124DFA25Q50625854-17B714E5-E6A1-4F00-9DA8-2033490C7F0AQ51739261-060763E1-7011-466A-84A9-12E14C85DDEAQ55020619-92D8CBA6-6FEB-4BED-9FC7-8733A0ADC2F6Q55228818-44BE6EF6-3DB1-4C23-8BFB-62A07EB5418C
P2860
Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Long-term stimulant treatment ...... n deficit hyperactive disorder
@ast
Long-term stimulant treatment ...... n deficit hyperactive disorder
@en
Long-term stimulant treatment ...... n deficit hyperactive disorder
@nl
type
label
Long-term stimulant treatment ...... n deficit hyperactive disorder
@ast
Long-term stimulant treatment ...... n deficit hyperactive disorder
@en
Long-term stimulant treatment ...... n deficit hyperactive disorder
@nl
prefLabel
Long-term stimulant treatment ...... n deficit hyperactive disorder
@ast
Long-term stimulant treatment ...... n deficit hyperactive disorder
@en
Long-term stimulant treatment ...... n deficit hyperactive disorder
@nl
P2093
P2860
P1433
P1476
Long-term stimulant treatment ...... n deficit hyperactive disorder
@en
P2093
Christopher T Wong
Frank Telang
Gene-Jack Wang
James M Swanson
Jean Logan
Jeffrey H Newcorn
Joanna S Fowler
Millard Jayne
Nora D Volkow
P2860
P304
P356
10.1371/JOURNAL.PONE.0063023
P407
P577
2013-05-15T00:00:00Z